IRIS
AMODIO, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 898
AS - Asia 768
EU - Europa 325
SA - Sud America 190
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 42
OC - Oceania 3
Totale 2.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 846
SG - Singapore 251
VN - Vietnam 158
CN - Cina 139
BR - Brasile 130
IT - Italia 123
BD - Bangladesh 53
HK - Hong Kong 52
DE - Germania 44
FR - Francia 40
AR - Argentina 23
AT - Austria 23
CA - Canada 22
UA - Ucraina 15
FI - Finlandia 14
GB - Regno Unito 14
IQ - Iraq 14
IN - India 13
KR - Corea 13
MX - Messico 12
CO - Colombia 9
SN - Senegal 9
ZA - Sudafrica 8
DZ - Algeria 7
ID - Indonesia 7
PK - Pakistan 7
RU - Federazione Russa 7
SE - Svezia 7
TR - Turchia 7
CL - Cile 6
EC - Ecuador 6
ES - Italia 5
NL - Olanda 5
PL - Polonia 5
PY - Paraguay 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
EG - Egitto 4
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BG - Bulgaria 3
JP - Giappone 3
KG - Kirghizistan 3
MA - Marocco 3
TN - Tunisia 3
AU - Australia 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SC - Seychelles 2
TG - Togo 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
NG - Nigeria 1
NI - Nicaragua 1
PF - Polinesia Francese 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.228
Salva come PNG Salva come JPEG
Città #
Dallas 224
Council Bluffs 121
Singapore 118
San Jose 76
Ashburn 70
Hong Kong 51
Ho Chi Minh City 47
Hanoi 46
Beijing 37
Chandler 35
New York 27
Lauterbourg 21
Los Angeles 19
Boardman 14
Helsinki 14
Vienna 14
Santa Clara 13
Seoul 13
Florence 12
Da Nang 11
Rende 11
Munich 10
São Paulo 10
Dakar 9
Hefei 9
Montreal 8
Shanghai 8
Guangzhou 7
Haiphong 7
Phoenix 7
Rome 7
San Mateo 7
Baghdad 6
Buenos Aires 6
Frankfurt am Main 6
São José do Rio Preto 6
Chicago 5
Jacksonville 5
Medellín 5
Mexico City 5
Milan 5
Rio de Janeiro 5
Tashkent 5
Biên Hòa 4
Bremen 4
Brescia 4
Buffalo 4
Duhok 4
Elk Grove Village 4
Falkenstein 4
Goiânia 4
Lawrence 4
Naples 4
Riyadh 4
Secaucus 4
Tianjin 4
Toronto 4
Warsaw 4
Acerra 3
Bari 3
Brussels 3
Caracas 3
Catania 3
Charlotte 3
Dearborn 3
Fortaleza 3
Genoa 3
Houston 3
Izmir 3
Las Vegas 3
London 3
Mauá 3
Mosul 3
Noida 3
Ogden 3
Omaha 3
Orem 3
Portsmouth 3
Recife 3
Redwood City 3
Roxbury 3
Salvador 3
Turin 3
Uberlândia 3
Wuhan 3
Abu Dhabi 2
Amman 2
Amsterdam 2
Asunción 2
Aversa 2
Baku 2
Baltimore 2
Bandar Seri Begawan 2
Bishkek 2
Borgomanero 2
Boston 2
Brooklyn 2
Cairo 2
Cape Town 2
Casablanca 2
Totale 1.313
Salva come PNG Salva come JPEG
Nome #
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options? 182
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 153
First evidence on the novel hypothalamic peptide Phoenixin-14 as cardiac modulator and cardioprotective in normal and obese rats 147
Vaccination in Multiple Myeloma: Challenges and Strategies 144
Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction 137
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple Myeloma 131
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 128
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 115
Epigenetic regulation of mitochondrial quality control genes in multiple myeloma: A sequenom massarray pilot investigation on hmcls 109
Rilzabrutinib for the Treatment of Immune Thrombocytopenia 83
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 82
Discovery of a Promising Hydroxyamino-Piperidine HDAC6 Inhibitor via Integrated Virtual Screening and Experimental Validation in Multiple Myeloma 80
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients 76
Maintenance therapy after ASCT in newly diagnosed multiple myeloma patients: single agent versus combination drugs 72
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions 67
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents 53
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 45
Real‐World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia 35
Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy 35
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug Development 33
The Non-Coding RNA Journal Club: Highlights on Recent Papers-14 32
Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies 30
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 26
Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy 26
Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis 24
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 22
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 21
Reshaping multiple myeloma treatment: recent breakthroughs 21
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies 21
Comparative efficacy of different therapeutic approaches in treatment naïve FLT3-mutated AML eligible for intensive chemotherapy: a Bayesian network meta-analysis of randomized trials 20
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 19
Targeting the Menin– KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation 19
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 18
Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions 15
Targeting Ikaros and Aiolos: Next‐Generation Cereblon E3 Ligase Modulators in MM 13
Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives 11
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies 9
From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management 8
To Treat or Not to Treat: Navigating Early‐Stage CLL in the Era of Targeted Therapy 7
Gut Microbiota and Acute Myeloid Leukemia: State of the Art, Clinical Signals, and Translational Opportunities 7
First‐Line Treatment of IGHV ‐Unmutated Chronic Lymphocytic Leukemia: A Network Meta‐Analysis of Targeted and Chemoimmunotherapy Regimens 6
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities 6
High-dose ruxolitinib (25 mg twice daily) in myelofibrosis: feasibility, safety, and long-term treatment exposure in a real-world cohort 5
Totale 2.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.734
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202246 0 3 1 5 2 1 1 14 1 2 5 11
2022/202391 10 12 3 12 14 5 2 10 14 1 5 3
2023/202494 11 5 8 10 2 17 9 1 5 5 10 11
2024/2025184 11 15 5 11 3 5 5 7 26 24 12 60
2025/20261.630 64 114 227 117 198 123 118 87 158 208 128 88
2026/2027213 159 54 0 0 0 0 0 0 0 0 0 0
Totale 2.293